- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of severe COVID-19: an evolving paradigm
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-5
Publisher
Informa UK Limited
Online
2022-10-22
DOI
10.1080/14656566.2022.2140041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes
- (2022) Yuji Joyo et al. IMMUNOLOGIC RESEARCH
- The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
- (2022) Melanie D. Whittington et al. VALUE IN HEALTH
- Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
- (2022) Ismael Francisco Aomar-Millán et al. Reumatologia Clinica
- Treatment strategies of COVID-19: A rheumatology perspective
- (2022) Alexandros A. Drosos et al. European Journal of Internal Medicine
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- BARICITINIB ATTENUATES THE PROINFLAMMATORY PHASE OF COVID-19 DRIVEN BY LUNG-INFILTRATING MONOCYTES
- (2022) Brian Dobosh et al. Cell Reports
- Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study
- (2022) Bill J Wright et al. Lancet Respiratory Medicine
- Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
- (2022) Wendao Li et al. Frontiers in Immunology
- Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis
- (2022) Minglei Yang et al. Precision Clinical Medicine
- Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
- (2022) Daniele Zama et al. ANNALS OF HEMATOLOGY
- COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes
- (2022) Germaine Wong et al. TRANSPLANTATION
- COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
- (2022) Sarah E. Conway et al. Multiple Sclerosis and Related Disorders
- Can Obesity Prevalence Explain COVID-19 Indicators (Cases, Mortality, and Recovery)? A Comparative Study in OECD Countries
- (2022) Yuval Arbel et al. Journal of Obesity
- Baseline Thrombocytopenia and Disease Severity Among COVID-19 Patients, Tibebe Ghion Specialized Hospital COVID-19 Treatment Center, Northwest Ethiopia
- (2022) Fikir Asrie et al. Journal of Blood Medicine
- Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
- (2022) Ruth Alex et al. Advances in Virology
- Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
- (2021) Rogan A. Grant et al. NATURE
- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
- (2021) Viviane C Veiga et al. BMJ-British Medical Journal
- Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis
- (2021) Xiaobo He et al. Frontiers in Public Health
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- 2020 Year in Review: Pharmacologic Treatments for COVID-19
- (2021) Jessica L. Saunders et al. Respiratory Care
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study
- (2021) Gianluca Russo et al. PLoS One
- Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis
- (2021) Stephen E. Congly et al. Scientific Reports
- Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic
- (2021) Naim Mahroum et al. International Journal of Environmental Research and Public Health
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support–free days
- (2021) Anthony A. Donato ANNALS OF INTERNAL MEDICINE
- Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
- (2021) Mario Witkowski et al. NATURE
- Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis
- (2021) Michael J. Murphy et al. JAMA Dermatology
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
- (2020) Tapan Behl et al. LIFE SCIENCES
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope
- (2020) Arun Kumar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)
- (2014) Kazuya Shirato et al. Virology Journal
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started